Literature DB >> 56916

Inhibition of dihydrostreptomycin binding to Mycobacterium smegmatis by monovalent and divalent cation salts.

W H Beggs, F A Andrews.   

Abstract

To better understand salt antagonism of dihydrostreptomycin (DSM) action on Mycobacterium smegmatis, the effects of monovalent and divalent cation salts on drug uptake were studied in relation to the lethal activity of DSM. In Sauton liquid medium NaCl, MgCl(2), and SrCl(2) inhibited the initial instantaneous binding of [(3)H]DSM to the organism and suppressed secondary uptake. These data correlated well with the capacity of each salt to prevent the lethal activity of DSM. It was concluded that monovalent and divalent cation salt antagonism of DSM action on M. smegmatis involves nonspecific interference with drug uptake.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 56916      PMCID: PMC429542          DOI: 10.1128/AAC.9.3.393

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  THE SEQUENCE OF SOME EFFECTS OF STREPTOMYCIN IN ESCHERICHIA COLI.

Authors:  D T DUBIN; R HANCOCK; B D DAVIS
Journal:  Biochim Biophys Acta       Date:  1963-08-13

2.  Uptake of streptomycin by Escherichia coli.

Authors:  N ANAND; B D DAVIS; A K ARMITAGE
Journal:  Nature       Date:  1960-01-02       Impact factor: 49.962

3.  The Influence of Certain Substances on the Activity of Streptomycin: III. Differential Effects of Various Electrolytes on the Action of Streptomycin.

Authors:  R Donovick; A P Bayan; P Canales; F Pansy
Journal:  J Bacteriol       Date:  1948-07       Impact factor: 3.490

4.  Studies on Streptomycin: I. Factors Influencing the Activity of Streptomycin.

Authors:  S Berkman; R J Henry; R D Housewright
Journal:  J Bacteriol       Date:  1947-05       Impact factor: 3.490

5.  Influence of salts on the uptake of streptomycin by Escherichia coli.

Authors:  P H PLOTZ; D T DUBIN; B D DAVIS
Journal:  Nature       Date:  1961-09-23       Impact factor: 49.962

6.  The intracellular accumulation of 14-C-streptomycin by Escherichia coli strain B in relation to its growth-inhibitory effect.

Authors:  M Kogut; J W Lightbown; P Isaacson
Journal:  J Gen Microbiol       Date:  1966-03

7.  Effect of salt concentration on the apparent in-vitro susceptibility of Pseudomonas and other gram-negative bacilli to gentamicin.

Authors:  A A Medeiros; T F O'Brien; W E Wacker; N F Yulug
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

8.  Effect of the concentrations of magnesium and calcium on the in-vitro susceptibility of Pseudomonas aeruginosa to gentamicin.

Authors:  D N Gilbert; E Kutscher; P Ireland; J A Barnett; J P Sanford
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

9.  Accumulation of label from C14-streptomycin by Escherichia coli.

Authors:  C HURWITZ; C L ROSANO
Journal:  J Bacteriol       Date:  1962-06       Impact factor: 3.490

10.  Protection of Mycobacterium smegmatis from Ethambutol and Streptomycin Inhibition by MgSO(4) and Polyamines.

Authors:  W H Beggs; N E Williams
Journal:  Infect Immun       Date:  1971-03       Impact factor: 3.441

View more
  4 in total

1.  Bacillus subtilis mutants dependent on streptomycin.

Authors:  G R Quan; K M Campbell; G H Chambliss
Journal:  Mol Gen Genet       Date:  1979-09

2.  Gentamicin does not chelate calcium.

Authors:  S J Kohlhepp; S B Plant; D A McCarron; D N Gilbert
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

3.  Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria.

Authors:  L E Bryan; H M Van Den Elzen
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

4.  Verapamil, and its metabolite norverapamil, inhibit macrophage-induced, bacterial efflux pump-mediated tolerance to multiple anti-tubercular drugs.

Authors:  Kristin N Adams; John D Szumowski; Lalita Ramakrishnan
Journal:  J Infect Dis       Date:  2014-02-14       Impact factor: 5.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.